Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
19
SSMXY Quote, Financials, Valuation and Earnings
Last price:
$8.60
Seasonality move
:
2.98%
Day range:
$8.32 - $8.60
52-week range:
$8.15 - $19.85
Dividend yield:
0%
P/E ratio:
18.03x
P/S ratio:
1.60x
P/B ratio:
1.68x
Volume:
166.2K
Avg. volume:
243.3K
1-year change:
-53.01%
Market cap:
$5.4B
Revenue:
$3.3B
EPS (TTM):
$0.48
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SSMXY
Sysmex Corp.
|
-- | -- | -- | -- | -- |
|
AMGXF
AnGes, Inc.
|
-- | -- | -- | -- | -- |
|
HLOSF
Healios KK
|
-- | -- | -- | -- | -- |
|
PPTDF
PeptiDream Inc.
|
-- | -- | -- | -- | -- |
|
SOLTF
Nxera Pharma Co., Ltd.
|
-- | -- | -- | -- | -- |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SSMXY
Sysmex Corp.
|
$8.60 | -- | $5.4B | 18.03x | $0.12 | 0% | 1.60x |
|
AMGXF
AnGes, Inc.
|
$0.36 | -- | $139.1M | -- | $0.00 | 0% | 20.32x |
|
HLOSF
Healios KK
|
$2.10 | -- | $243M | -- | $0.00 | 0% | 308.70x |
|
PPTDF
PeptiDream Inc.
|
$8.85 | -- | $1.1B | 13.79x | $0.00 | 0% | 9.26x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$5.44 | -- | $492.3M | -- | $0.00 | 0% | 2.47x |
|
STMM
Stemcell Holdings, Inc.
|
$0.06 | -- | $60M | -- | $0.00 | 0% | 0.17x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SSMXY
Sysmex Corp.
|
12.42% | -0.671 | 7.45% | 2.12x |
|
AMGXF
AnGes, Inc.
|
1.74% | 0.000 | 0.25% | 0.89x |
|
HLOSF
Healios KK
|
34.82% | -0.193 | 7.46% | 1.83x |
|
PPTDF
PeptiDream Inc.
|
24.85% | 0.074 | 6.74% | 1.48x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
48.47% | 1.070 | 73.82% | 1.61x |
|
STMM
Stemcell Holdings, Inc.
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SSMXY
Sysmex Corp.
|
$422.4M | $100.6M | 8.29% | 9.42% | 12.05% | $9M |
|
AMGXF
AnGes, Inc.
|
$399.5K | -$10.4M | -153.93% | -162.7% | -703% | -- |
|
HLOSF
Healios KK
|
-$798.3K | -$6.6M | -44.36% | -88.96% | -4043.07% | -$5.3M |
|
PPTDF
PeptiDream Inc.
|
$17.4M | -$6M | -5.23% | -7.06% | -16.33% | -$2.4M |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$37.1M | -$8.9M | -9.66% | -19.06% | -17.59% | -$1M |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
Sysmex Corp. vs. Competitors
-
Which has Higher Returns SSMXY or AMGXF?
AnGes, Inc. has a net margin of 11.4% compared to Sysmex Corp.'s net margin of -190.55%. Sysmex Corp.'s return on equity of 9.42% beat AnGes, Inc.'s return on equity of -162.7%.
Company Gross Margin Earnings Per Share Invested Capital SSMXYSysmex Corp.50.59% $0.15 $3.7B AMGXFAnGes, Inc.27% -$0.01 $20M -
What do Analysts Say About SSMXY or AMGXF?
Sysmex Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand AnGes, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sysmex Corp. has higher upside potential than AnGes, Inc., analysts believe Sysmex Corp. is more attractive than AnGes, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSMXYSysmex Corp.0 0 0 AMGXFAnGes, Inc.0 0 0 -
Is SSMXY or AMGXF More Risky?
Sysmex Corp. has a beta of 1.137, which suggesting that the stock is 13.726% more volatile than S&P 500. In comparison AnGes, Inc. has a beta of 0.068, suggesting its less volatile than the S&P 500 by 93.218%.
-
Which is a Better Dividend Stock SSMXY or AMGXF?
Sysmex Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0%. AnGes, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sysmex Corp. pays 24.69% of its earnings as a dividend. AnGes, Inc. pays out -- of its earnings as a dividend. Sysmex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSMXY or AMGXF?
Sysmex Corp. quarterly revenues are $834.9M, which are larger than AnGes, Inc. quarterly revenues of $1.5M. Sysmex Corp.'s net income of $95.2M is higher than AnGes, Inc.'s net income of -$2.8M. Notably, Sysmex Corp.'s price-to-earnings ratio is 18.03x while AnGes, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sysmex Corp. is 1.60x versus 20.32x for AnGes, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSMXYSysmex Corp.1.60x 18.03x $834.9M $95.2M AMGXFAnGes, Inc.20.32x -- $1.5M -$2.8M
-
Which has Higher Returns SSMXY or HLOSF?
Healios KK has a net margin of 11.4% compared to Sysmex Corp.'s net margin of -9751.87%. Sysmex Corp.'s return on equity of 9.42% beat Healios KK's return on equity of -88.96%.
Company Gross Margin Earnings Per Share Invested Capital SSMXYSysmex Corp.50.59% $0.15 $3.7B HLOSFHealios KK-491.87% $0.12 $47.9M -
What do Analysts Say About SSMXY or HLOSF?
Sysmex Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healios KK has an analysts' consensus of -- which suggests that it could fall by --. Given that Sysmex Corp. has higher upside potential than Healios KK, analysts believe Sysmex Corp. is more attractive than Healios KK.
Company Buy Ratings Hold Ratings Sell Ratings SSMXYSysmex Corp.0 0 0 HLOSFHealios KK0 0 0 -
Is SSMXY or HLOSF More Risky?
Sysmex Corp. has a beta of 1.137, which suggesting that the stock is 13.726% more volatile than S&P 500. In comparison Healios KK has a beta of 0.262, suggesting its less volatile than the S&P 500 by 73.819%.
-
Which is a Better Dividend Stock SSMXY or HLOSF?
Sysmex Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0%. Healios KK offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sysmex Corp. pays 24.69% of its earnings as a dividend. Healios KK pays out -- of its earnings as a dividend. Sysmex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSMXY or HLOSF?
Sysmex Corp. quarterly revenues are $834.9M, which are larger than Healios KK quarterly revenues of $162.3K. Sysmex Corp.'s net income of $95.2M is higher than Healios KK's net income of $12.4M. Notably, Sysmex Corp.'s price-to-earnings ratio is 18.03x while Healios KK's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sysmex Corp. is 1.60x versus 308.70x for Healios KK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSMXYSysmex Corp.1.60x 18.03x $834.9M $95.2M HLOSFHealios KK308.70x -- $162.3K $12.4M
-
Which has Higher Returns SSMXY or PPTDF?
PeptiDream Inc. has a net margin of 11.4% compared to Sysmex Corp.'s net margin of -9.39%. Sysmex Corp.'s return on equity of 9.42% beat PeptiDream Inc.'s return on equity of -7.06%.
Company Gross Margin Earnings Per Share Invested Capital SSMXYSysmex Corp.50.59% $0.15 $3.7B PPTDFPeptiDream Inc.47.44% -$0.03 $437.5M -
What do Analysts Say About SSMXY or PPTDF?
Sysmex Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand PeptiDream Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sysmex Corp. has higher upside potential than PeptiDream Inc., analysts believe Sysmex Corp. is more attractive than PeptiDream Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSMXYSysmex Corp.0 0 0 PPTDFPeptiDream Inc.0 0 0 -
Is SSMXY or PPTDF More Risky?
Sysmex Corp. has a beta of 1.137, which suggesting that the stock is 13.726% more volatile than S&P 500. In comparison PeptiDream Inc. has a beta of 0.573, suggesting its less volatile than the S&P 500 by 42.666%.
-
Which is a Better Dividend Stock SSMXY or PPTDF?
Sysmex Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0%. PeptiDream Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sysmex Corp. pays 24.69% of its earnings as a dividend. PeptiDream Inc. pays out -- of its earnings as a dividend. Sysmex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSMXY or PPTDF?
Sysmex Corp. quarterly revenues are $834.9M, which are larger than PeptiDream Inc. quarterly revenues of $36.8M. Sysmex Corp.'s net income of $95.2M is higher than PeptiDream Inc.'s net income of -$3.5M. Notably, Sysmex Corp.'s price-to-earnings ratio is 18.03x while PeptiDream Inc.'s PE ratio is 13.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sysmex Corp. is 1.60x versus 9.26x for PeptiDream Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSMXYSysmex Corp.1.60x 18.03x $834.9M $95.2M PPTDFPeptiDream Inc.9.26x 13.79x $36.8M -$3.5M
-
Which has Higher Returns SSMXY or SOLTF?
Nxera Pharma Co., Ltd. has a net margin of 11.4% compared to Sysmex Corp.'s net margin of -99.41%. Sysmex Corp.'s return on equity of 9.42% beat Nxera Pharma Co., Ltd.'s return on equity of -19.06%.
Company Gross Margin Earnings Per Share Invested Capital SSMXYSysmex Corp.50.59% $0.15 $3.7B SOLTFNxera Pharma Co., Ltd.73.58% -$0.55 $755.2M -
What do Analysts Say About SSMXY or SOLTF?
Sysmex Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nxera Pharma Co., Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sysmex Corp. has higher upside potential than Nxera Pharma Co., Ltd., analysts believe Sysmex Corp. is more attractive than Nxera Pharma Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SSMXYSysmex Corp.0 0 0 SOLTFNxera Pharma Co., Ltd.0 0 0 -
Is SSMXY or SOLTF More Risky?
Sysmex Corp. has a beta of 1.137, which suggesting that the stock is 13.726% more volatile than S&P 500. In comparison Nxera Pharma Co., Ltd. has a beta of 0.018, suggesting its less volatile than the S&P 500 by 98.16%.
-
Which is a Better Dividend Stock SSMXY or SOLTF?
Sysmex Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0%. Nxera Pharma Co., Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sysmex Corp. pays 24.69% of its earnings as a dividend. Nxera Pharma Co., Ltd. pays out -- of its earnings as a dividend. Sysmex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSMXY or SOLTF?
Sysmex Corp. quarterly revenues are $834.9M, which are larger than Nxera Pharma Co., Ltd. quarterly revenues of $50.4M. Sysmex Corp.'s net income of $95.2M is higher than Nxera Pharma Co., Ltd.'s net income of -$50.1M. Notably, Sysmex Corp.'s price-to-earnings ratio is 18.03x while Nxera Pharma Co., Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sysmex Corp. is 1.60x versus 2.47x for Nxera Pharma Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSMXYSysmex Corp.1.60x 18.03x $834.9M $95.2M SOLTFNxera Pharma Co., Ltd.2.47x -- $50.4M -$50.1M
-
Which has Higher Returns SSMXY or STMM?
Stemcell Holdings, Inc. has a net margin of 11.4% compared to Sysmex Corp.'s net margin of --. Sysmex Corp.'s return on equity of 9.42% beat Stemcell Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SSMXYSysmex Corp.50.59% $0.15 $3.7B STMMStemcell Holdings, Inc.-- -- -- -
What do Analysts Say About SSMXY or STMM?
Sysmex Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stemcell Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Sysmex Corp. has higher upside potential than Stemcell Holdings, Inc., analysts believe Sysmex Corp. is more attractive than Stemcell Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SSMXYSysmex Corp.0 0 0 STMMStemcell Holdings, Inc.0 0 0 -
Is SSMXY or STMM More Risky?
Sysmex Corp. has a beta of 1.137, which suggesting that the stock is 13.726% more volatile than S&P 500. In comparison Stemcell Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SSMXY or STMM?
Sysmex Corp. has a quarterly dividend of $0.12 per share corresponding to a yield of 0%. Stemcell Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sysmex Corp. pays 24.69% of its earnings as a dividend. Stemcell Holdings, Inc. pays out -- of its earnings as a dividend. Sysmex Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSMXY or STMM?
Sysmex Corp. quarterly revenues are $834.9M, which are larger than Stemcell Holdings, Inc. quarterly revenues of --. Sysmex Corp.'s net income of $95.2M is higher than Stemcell Holdings, Inc.'s net income of --. Notably, Sysmex Corp.'s price-to-earnings ratio is 18.03x while Stemcell Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sysmex Corp. is 1.60x versus 0.17x for Stemcell Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSMXYSysmex Corp.1.60x 18.03x $834.9M $95.2M STMMStemcell Holdings, Inc.0.17x -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
